Passa al contenuto
Merck
Tutte le immagini(2)

Documenti

69311

Supelco

Quinine

certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland

Sinonimo/i:

6′-Methoxycinchonidine

Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali
Tutte le immagini(2)

About This Item

Formula empirica (notazione di Hill):
C20H24N2O2
Numero CAS:
130-95-0
Peso molecolare:
324.42
Beilstein:
91867
Numero CE:
205-003-2
Numero MDL:
MFCD00198096
Codice UNSPSC:
41116107
ID PubChem:
329761562
NACRES:
NA.24

Grado

certified reference material
TraceCERT®

Livello qualitativo

300

Nome Commerciale

TraceCERT®

Durata

limited shelf life, expiry date on the label

Produttore/marchio commerciale

Manufactured by: Sigma-Aldrich Production GmbH, Switzerland

Condizioni di stoccaggio

under inert gas

tecniche

HPLC: suitable
gas chromatography (GC): suitable

Punto di fusione

173-175 °C (lit.)

applicazioni

food and beverages

Formato

neat

Stringa SMILE

COc1ccc2nccc([C@@H](O)[C@@H]3C[C@@H]4CCN3C[C@@H]4C=C)c2c1

InChI

1S/C20H24N2O2/c1-3-13-12-22-9-7-14(13)10-19(22)20(23)16-6-8-21-18-5-4-15(24-2)11-17(16)18/h3-6,8,11,13-14,19-20,23H,1,7,9-10,12H2,2H3/t13-,14-,19-,20+/m0/s1
LOUPRKONTZGTKE-WZBLMQSHSA-N

Cerchi prodotti simili? Visita Guida al confronto tra prodotti

Descrizione generale

This certified reference material (CRM) is produced and certified in accordance with ISO/IEC 17025 and ISO 17034. This CRM is traceable to primary material from an NMI, e.g. NIST or NMIJ.
Certified content by quantitative NMR incl. uncertainty and expiry date are given on the certificate.
Download your certificate at: http://www.sigma-aldrich.com.

Applicazioni

Refer to the product′s Certificate of Analysis for more information on a suitable instrument technique. Contact Technical Service for further support.

Azioni biochim/fisiol

Potassium channel blocker

Confezionamento

Bottomless glass bottle. Contents are inside inserted fused cone.

Avvertenza

Store under argon.

Note legali

TraceCERT is a registered trademark of Merck KGaA, Darmstadt, Germany

Pittogrammi

Exclamation mark
GHS07

Avvertenze

Warning

Indicazioni di pericolo

H302,H317

Classi di pericolo

Acute Tox. 4 Oral - Skin Sens. 1

Codice della classe di stoccaggio

11 - Combustible Solids

Classe di pericolosità dell'acqua (WGK)

WGK 1

Choose from one of the most recent versions:

Certificati d'analisi (COA)

Lot/Batch Number
BCCF7920
BCBV4559
BCBM5794V
BCBG6955V
BCBG6955

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti

I clienti hanno visto anche

Slide 1 of 7

1 of 7

(-)-Dihydroquinine phyproof® Reference Substance

PHL80965

(-)-Dihydroquinine

Quinidine anhydrous

Sigma-Aldrich

Q3625

Quinidine

Quinine hydrochloride dihydrate United States Pharmacopeia (USP) Reference Standard

USP

1596807

Quinine hydrochloride dihydrate

Quinine hydrochloride dihydrate suitable for fluorescence, BioReagent, ≥98.0% (NT)

Sigma-Aldrich

22630

Quinine hydrochloride dihydrate

Quinine monohydrochloride dihydrate ≥95%, FG

Sigma-Aldrich

W297607

Quinine monohydrochloride dihydrate

Quinine hydrochloride dihydrate tested according to Ph. Eur.

Sigma-Aldrich

22632

Quinine hydrochloride dihydrate

Quinidine crystallized, ≥98.0% (dried material, NT)

Sigma-Aldrich

22600

Quinidine

George Praygod et al.
Malaria journal, 7, 210-210 (2008-10-22)
The efficacy of intravenous quinine, which is the mainstay for treating severe malaria in children, is decreasing in South East Asia and Africa. Artemisinin derivatives are a potential alternative to quinine. However, their efficacy compared to quinine in treating severe
Jane Achan et al.
Malaria journal, 10, 144-144 (2011-05-26)
Quinine remains an important anti-malarial drug almost 400 years after its effectiveness was first documented. However, its continued use is challenged by its poor tolerability, poor compliance with complex dosing regimens, and the availability of more efficacious anti-malarial drugs. This
Hmwe Hmwe Kyu et al.
Bulletin of the World Health Organization, 87(12), 896-904 (2010-05-11)
To summarize the existing evidence on the efficacy of artemether and arteether, two artemisinin derivatives, versus quinine for treating cerebral malaria in children. We searched the Cochrane Central Register of Controlled Trials, MEDLINE, EMBASE and the http://clinicaltrials.gov web site. We
Karen M Kiang et al.
Archives of disease in childhood. Education and practice edition, 98(1), 7-15 (2012-11-23)
Since the 2010 publication in this journal of a review of the management of imported malaria for U.K. children, new evidence for the treatment of both severe and uncomplicated malaria has been published. This review discusses these new data and
B Darpo et al.
Clinical pharmacology and therapeutics, 97(4), 326-335 (2015-02-12)
The QT effects of five "QT-positive" and one negative drug were tested to evaluate whether exposure-response analysis can detect QT effects in a small study with healthy subjects. Each drug was given to nine subjects (six for placebo) in two
Visualizza tutti i documenti correlati

Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..

Contatta l'Assistenza Tecnica.